Literature DB >> 15044537

Suprachiasmatic nuclei grafts restore the circadian rhythm in the paraventricular nucleus of the hypothalamus.

Ehab Tousson1, Hilmar Meissl.   

Abstract

The mammalian suprachiasmatic nucleus (SCN) controls the circadian rhythm of many physiological and behavioral events by an orchestrated output of the electrical activity of SCN neurons. We examined the propagation of output signals from the SCN into the hypothalamus, especially into the region of the paraventricular nucleus, through multimicroelectrode recordings using acute and organotypic brain slices. Circadian rhythms in spontaneous firing rate with a period close to 24 hr were demonstrated in the SCN, in directly adjacent hypothalamic regions, and in the region of the paraventricular nucleus of the hypothalamus, an important center for the integration of neuroendocrine, homeostatic, and autonomic functions. The activity rhythms recorded from structures outside of the SCN were in phase with the rhythms in the SCN. Cyclic information in the hypothalamus was lost after ablation of the SCN but could be restored by SCN grafts, indicating that a humoral factor is responsible for the restoration of circadian rhythmicity in the absence of neural connections. Periodic application of arginine-vasopressin (AVP) provided evidence that AVP can induce rhythmicity in the hypothalamus. These data indicate that the SCN uses a dual (neuronal and humoral) mechanism for communication with its targets in the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044537      PMCID: PMC6729855          DOI: 10.1523/JNEUROSCI.5044-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  Plasticity and specificity of the circadian epigenome.

Authors:  Selma Masri; Paolo Sassone-Corsi
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

Review 2.  Central mechanisms of HPA axis regulation by voluntary exercise.

Authors:  Alexis M Stranahan; Kim Lee; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2008-02-14       Impact factor: 3.843

3.  Geniculohypothalamic GABAergic projections gate suprachiasmatic nucleus responses to retinal input.

Authors:  Lydia Hanna; Lauren Walmsley; Abigail Pienaar; Michael Howarth; Timothy M Brown
Journal:  J Physiol       Date:  2017-04-11       Impact factor: 5.182

4.  Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.

Authors:  Jérôme Mordel; Diana Karnas; Alexey Inyushkin; Etienne Challet; Paul Pévet; Hilmar Meissl
Journal:  J Physiol       Date:  2011-03-08       Impact factor: 5.182

Review 5.  Collective timekeeping among cells of the master circadian clock.

Authors:  Jennifer A Evans
Journal:  J Endocrinol       Date:  2016-05-06       Impact factor: 4.286

Review 6.  Circadian metabolism in the light of evolution.

Authors:  Zachary Gerhart-Hines; Mitchell A Lazar
Journal:  Endocr Rev       Date:  2015-04-30       Impact factor: 19.871

7.  Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment.

Authors:  Guo Zhang; Dongsheng Cai
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-09       Impact factor: 4.310

Review 8.  Sex differences in circadian timing systems: implications for disease.

Authors:  Matthew Bailey; Rae Silver
Journal:  Front Neuroendocrinol       Date:  2013-11-25       Impact factor: 8.606

9.  Central clock regulates the cervically stimulated prolactin surges by modulation of dopamine and vasoactive intestinal polypeptide release in ovariectomized rats.

Authors:  Maristela O Poletini; Jessica E Kennett; De'nise T McKee; Marc E Freeman
Journal:  Neuroendocrinology       Date:  2009-10-29       Impact factor: 4.914

10.  Differential maturation of circadian rhythms in clock gene proteins in the suprachiasmatic nucleus and the pars tuberalis during mouse ontogeny.

Authors:  Nariman Ansari; Manuel Agathagelidis; Choogon Lee; Horst-Werner Korf; Charlotte von Gall
Journal:  Eur J Neurosci       Date:  2009-02       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.